Gender differences in secondary prevention of coronary heart disease: reasons to worry or not?

Abstract

In general, a gender-equal level of lipid control and access to medical drug treatment has been established for patients in secondary prevention from a national sample in Sweden, followed for 1 year after CHD manifestations and related interventions.